Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q2
$754K Sell
4,184
-45
-1% -$8.3K 0.28% 86
2020
Q1
$700K Buy
4,229
+135
+3% +$26.4K 0.33% 79
2019
Q4
$858K Sell
4,094
-45
-1% -$9.34K 0.32% 85
2019
Q3
$892K Buy
4,139
+85
+2% +$18.2K 0.36% 76
2019
Q2
$825K Buy
4,054
+50
+1% +$9.55K 0.34% 78
2019
Q1
$798K Buy
4,004
+555
+16% +$99.9K 0.34% 79
2018
Q4
$539K Buy
3,449
+1,657
+92% +$277K 0.31% 93
2018
Q3
$317K Buy
1,792
+125
+7% +$21.3K 0.16% 167
2018
Q2
$282K Buy
1,667
+91
+6% +$15.3K 0.16% 157
2018
Q1
$251K Buy
+1,576
New +$254K 0.15% 154

Other funds holding SYK

Summit X LLC's SYK Position: Q2 2020 in Review

Summit X LLC reduced its Stryker (SYK) stake by 1.1% in Q2 2020, selling an estimated $8.3K and leaving 4,184 shares worth $754K. The position accounts for 0.28% of the portfolio, ranked #86.

Summit X LLC first reported a position in SYK in Q1 2018 and has held it in 10 quarters since. The position peaked at $892K in Q3 2019. 1,405 funds tracked by Wall St. Rank hold SYK as of Q2 2020.

  • Summit X LLC held 4,184 shares of Stryker worth $754K as of Q2 2020.
  • Summit X LLC sold 45 Stryker shares in Q2 2020, an estimated $8.3K.
  • Stryker made up 0.28% of Summit X LLC's portfolio in Q2 2020, its #86 holding.
  • Summit X LLC first reported a position in Stryker in Q1 2018 and has held it in 10 quarters since.
  • Summit X LLC's Stryker position peaked at $892K in Q3 2019.
  • 1,405 funds tracked by Wall St. Rank held Stryker as of Q2 2020.

Based on Summit X LLC's 13F filing for Q2 2020, filed 13 Aug 2020.